학술논문
Intravenous immunoglobulins in patients with COVID-19-associated moderate-to-severe acute respiratory distress syndrome (ICAR): multicentre, double-blind, placebo-controlled, phase 3 trial
Document Type
Article
Author
Mazeraud, A.; Latroche, C.; Schimpf, C.; Rieu, C.; Sharshar, T.; Megarbane, B.; Lucas, B.; Jamme, M.; Madeux, B.; Mancusi, R.L.; Sylla, K.; Bailly, K.; Siami, S.; Zarka, J.; Moneger, G.; Santoli, F.; Argaud, L.; Chillet, P.; Muller, G.; Bruel, C.; Asfar, P.; Beloncle, F.; Reignier, J.; Vinsonneau, C.; Amour, J.; Goulenok, C.; Lemaitre, C.; Rohaut, B.; Mateu, P.; De Rudnicki, S.; Mourvillier, B.; Declercq, P.-L.; Schwebel, C.; Stoclin, A.; Garnier, M.; Gaudry, S.; Lamer, C.; Aegerter, P.
Source
In: The Lancet Respiratory Medicine . (The Lancet Respiratory Medicine, February 2022, 10(2):158-166)
Subject
Language
English
ISSN
22132619
22132600
22132600